A109960 Share Price Performance
₩173.00
-226.00 (-56.64%)
Price ₩173.00
Share Pricen/a
Is APTOCROM (KOSDAQ:109960) A Risky Investment?
Feb 13
APTOCROM Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A109960 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
APTOCROM Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -25.18
- 14.96%
- -56.69%
- 2.0%
About A109960
- Founded
- 1998
- Employees
- 12
- CEO
- WebsiteView website
APTOCROM Inc. distributes pharmaceutical products in South Korea. It operates through pharmaceutical business, leasing business, and insulation divisions. The company is involved in design, manufacturing, and construction of insulation; design, manufacturing and installation of removable insulation materials; design, production, and construction of nuclear power plant special insulation; and foam glass insulation material molding and construction. It also offers medicines for the digestive system, including ijilong solution, gabespan soft capsule, etc.; and medicines for external skin, including lavender cream, barclax ointment, etc. In addition, the company is involved in real estate leasing, including office, laboratory, etc.; leasing business of pharmaceutical products; and equipment leasing. The company was formerly known as AP Healthcare Inc. and changed its name to APTOCROM Inc. in September 2025. APTOCROM Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.
